Back

Pro-inflammatory lipid profile in isolated adipocyte cultures from patients with congestive heart failure: a possible role in the development of cardiac cachexia.

28 August 2026 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Lipids, inflammation, and cardiometabolic risk Heart Failure ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Alice Bongrani

University Hospital of Parma, Parma (Italy)

6 More presentations in this session

Presentation thumbnail
Investigating the heart-liver-axis in metabolic dysfunction-associated steatohepatitis and acute myocardial infarction
Mr A. Jacobs (Edinburgh, GB)
Abstract Slides Video
Presentation thumbnail
Tumor necrosis factor-α deficiency attenuates obesity and mitigates the severity of CpcPH-HFpEF in mouse models
Miss L. Zimmermann (Cologne, DE)
Abstract Slides Video
Presentation thumbnail
Circulating ectoenzyme CD38 is associated with diastolic dysfunction in subjects with metabolic syndrome: a population-based cross-sectional study
Doctor S. Ministrini (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
Lp(a) impairs NK cell function potentially contributes to impaired immunity and increased cardiovascular disease risk
Doctor Y. Baumer (US)
Abstract Slides Video
Presentation thumbnail
Inflammatory burden, but not genetic variation, predicts attenuated LDL cholesterol reduction after ST-elevation myocardial infarction
Mr I. Simanauskas (Kaunas, LT)
Abstract Slides Video

Access the full session

Session thumbnail
Lipids, inflammation, and cardiometabolic risk

The Event

Event poster

ESC Congress 2026

28 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Exerkines crosstalk muscles, adipose tissua and functionality in patients with advanced heart failure with reduced ejection fraction.
28 August 2026
thumbnail
Congress Presentation
Lipid metabolism rewiring of the heart
2 September 2024
thumbnail
Congress Presentation
Immune-epicardial adiposity, associated with coronary artery disease, is modulated by semaglutide
30 August 2026
thumbnail
Congress Presentation
Epicardial fat remodeling in HFrEF: loss of buffering capacity and lipotoxic risk
31 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources